News
Trump signs executive order on drug pricing via 'most favored nation' model, GSK acquires $1.2B MASH program, Bayer cuts 2,000 jobs, and first CRISPR therapy treats infant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback